tiprankstipranks
BioLife Solutions (BLFS)
NASDAQ:BLFS
US Market
BLFS
BioLife Solutions
RESEARCH TOOLSreports
Want to see BLFS full AI Analyst Report?

BioLife Solutions (BLFS) Stock Forecast & Price Target

419 Followers
See the Price Targets and Ratings of:

BLFS Analyst Ratings

Hold
7Ratings
Hold
0 Buy
7 Hold
0 Sell
Based on 7 analysts giving stock ratings to
BioLife
Solutions
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BLFS Stock 12 Month Forecast

Average Price Target

$31.00
▲(3.40% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for BioLife Solutions in the last 3 months. The average price target is $31.00 with a high forecast of $31.00 and a low forecast of $31.00. The average price target represents a 3.40% change from the last price of $29.98.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"18":"$18","25":"$25","32":"$32","21.5":"$21.5","28.5":"$28.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":31,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$31.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":31,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$31.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":31,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$31.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[18,21.5,25,28.5,32],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28.49,28.68307692307692,28.876153846153844,29.069230769230767,29.26230769230769,29.455384615384613,29.64846153846154,29.841538461538462,30.034615384615385,30.22769230769231,30.42076923076923,30.613846153846154,30.806923076923077,{"y":31,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28.49,28.68307692307692,28.876153846153844,29.069230769230767,29.26230769230769,29.455384615384613,29.64846153846154,29.841538461538462,30.034615384615385,30.22769230769231,30.42076923076923,30.613846153846154,30.806923076923077,{"y":31,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28.49,28.68307692307692,28.876153846153844,29.069230769230767,29.26230769230769,29.455384615384613,29.64846153846154,29.841538461538462,30.034615384615385,30.22769230769231,30.42076923076923,30.613846153846154,30.806923076923077,{"y":31,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":21.66,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.805,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.34,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.13,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.87,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.41,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.18,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.33,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.52,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.29,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.21,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.63,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.49,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$31.00Average Price Target$31.00Lowest Price Target$31.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stephens Analyst forecast on BLFS
Steven Etoch
Stephens
Stephens
$32→$31
Hold
3.40%
Upside
Downgraded
07/27/26
BioLife Solutions downgraded to Equal Weight from Overweight at StephensBioLife Solutions downgraded to Equal Weight from Overweight at Stephens
TD Cowen Analyst forecast on BLFS
Brendan Smith
TD Cowen
TD Cowen
$33→$31
Hold
3.40%
Upside
Downgraded
07/23/26
TD Cowen downgrades BioLife Solutions (BLFS) to a Hold
Lake Street Analyst forecast on BLFS
Thomas Flaten
Lake Street
Lake Street
$31
Hold
3.40%
Upside
Downgraded
07/23/26
Hold Rating Maintained as Repligen Acquisition Caps BioLife Upside; Price Target Cut to $31 from $33
Jefferies Analyst forecast on BLFS
Matthew Stanton, CFA
Jefferies
Jefferies
$30→$31
Hold
3.40%
Upside
Downgraded
07/23/26
BioLife Solutions downgraded to Hold from Buy at JefferiesBioLife Solutions downgraded to Hold from Buy at Jefferies
H.C. Wainwright Analyst forecast on BLFS
Yi Chen
H.C. Wainwright
H.C. Wainwright
$32→$31
Hold
3.40%
Upside
Downgraded
07/23/26
BioLife Solutions downgraded to Neutral from Buy at H.C. WainwrightBioLife Solutions downgraded to Neutral from Buy at H.C. Wainwright
Maxim Group Analyst forecast on BLFS
Jason McCarthy
Maxim Group
Maxim Group
―
Hold
―
Downgraded
07/23/26
BioLife Solutions downgraded to Hold from Buy at MaximBioLife Solutions downgraded to Hold from Buy at Maxim
Craig-Hallum Analyst forecast on BLFS
Matt Hewitt
Craig-Hallum
Craig-Hallum
$31
Hold
3.40%
Upside
Downgraded
07/22/26
BioLife Solutions downgraded to Hold from Buy at Craig-HallumBioLife Solutions downgraded to Hold from Buy at Craig-Hallum
Northland Securities Analyst forecast on BLFS
Carl Byrnes
Northland Securities
Northland Securities
$34
Buy
13.41%
Upside
Reiterated
03/24/26
BioLife Solutions pullback creates buying opportunity, says NorthlandBioLife Solutions pullback creates buying opportunity, says Northland
KeyBanc Analyst forecast on BLFS
Paul Knight
KeyBanc
KeyBanc
$33
Buy
10.07%
Upside
Reiterated
10/03/25
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (NASDAQ: BLFS), Pacific Biosciences (NASDAQ: PACB) and Humana (NYSE: HUM)
Benchmark Co. Analyst forecast on BLFS
Robert Wasserman
Benchmark Co.
Benchmark Co.
$30
Buy
0.07%
Upside
Reiterated
08/11/25
Analysts Conflicted on These Healthcare Names: Green Thumb Industries (Other OTC: GTBIF), Doximity (NYSE: DOCS) and BioLife Solutions (NASDAQ: BLFS)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stephens Analyst forecast on BLFS
Steven Etoch
Stephens
Stephens
$32→$31
Hold
3.40%
Upside
Downgraded
07/27/26
BioLife Solutions downgraded to Equal Weight from Overweight at StephensBioLife Solutions downgraded to Equal Weight from Overweight at Stephens
TD Cowen Analyst forecast on BLFS
Brendan Smith
TD Cowen
TD Cowen
$33→$31
Hold
3.40%
Upside
Downgraded
07/23/26
TD Cowen downgrades BioLife Solutions (BLFS) to a Hold
Lake Street Analyst forecast on BLFS
Thomas Flaten
Lake Street
Lake Street
$31
Hold
3.40%
Upside
Downgraded
07/23/26
Hold Rating Maintained as Repligen Acquisition Caps BioLife Upside; Price Target Cut to $31 from $33
Jefferies Analyst forecast on BLFS
Matthew Stanton, CFA
Jefferies
Jefferies
$30→$31
Hold
3.40%
Upside
Downgraded
07/23/26
BioLife Solutions downgraded to Hold from Buy at JefferiesBioLife Solutions downgraded to Hold from Buy at Jefferies
H.C. Wainwright Analyst forecast on BLFS
Yi Chen
H.C. Wainwright
H.C. Wainwright
$32→$31
Hold
3.40%
Upside
Downgraded
07/23/26
BioLife Solutions downgraded to Neutral from Buy at H.C. WainwrightBioLife Solutions downgraded to Neutral from Buy at H.C. Wainwright
Maxim Group Analyst forecast on BLFS
Jason McCarthy
Maxim Group
Maxim Group
―
Hold
―
Downgraded
07/23/26
BioLife Solutions downgraded to Hold from Buy at MaximBioLife Solutions downgraded to Hold from Buy at Maxim
Craig-Hallum Analyst forecast on BLFS
Matt Hewitt
Craig-Hallum
Craig-Hallum
$31
Hold
3.40%
Upside
Downgraded
07/22/26
BioLife Solutions downgraded to Hold from Buy at Craig-HallumBioLife Solutions downgraded to Hold from Buy at Craig-Hallum
Northland Securities Analyst forecast on BLFS
Carl Byrnes
Northland Securities
Northland Securities
$34
Buy
13.41%
Upside
Reiterated
03/24/26
BioLife Solutions pullback creates buying opportunity, says NorthlandBioLife Solutions pullback creates buying opportunity, says Northland
KeyBanc Analyst forecast on BLFS
Paul Knight
KeyBanc
KeyBanc
$33
Buy
10.07%
Upside
Reiterated
10/03/25
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (NASDAQ: BLFS), Pacific Biosciences (NASDAQ: PACB) and Humana (NYSE: HUM)
Benchmark Co. Analyst forecast on BLFS
Robert Wasserman
Benchmark Co.
Benchmark Co.
$30
Buy
0.07%
Upside
Reiterated
08/11/25
Analysts Conflicted on These Healthcare Names: Green Thumb Industries (Other OTC: GTBIF), Doximity (NYSE: DOCS) and BioLife Solutions (NASDAQ: BLFS)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BBOTBridgeBio Oncology Therapeutics
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering BioLife Solutions

3 Months
Carl ByrnesNorthland Securities
Success Rate
22/32 ratings generated profit
69%
Average Return
+20.14%
Copying Carl Byrnes's trades and holding each position for 3 Months would result in 68.75% of your transactions generating a profit, with an average return of +20.14% per trade.
1 Year
Carl ByrnesNorthland Securities
Success Rate
21/32 ratings generated profit
66%
Average Return
+29.00%
Copying Carl Byrnes's trades and holding each position for 1 Year would result in 65.63% of your transactions generating a profit, with an average return of +29.00% per trade.
2 Years
Paul KnightKeyBanc
Success Rate
8/9 ratings generated profit
89%
Average Return
+71.99%
Copying Paul Knight's trades and holding each position for 2 Years would result in 88.89% of your transactions generating a profit, with an average return of +71.99% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BLFS Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
6
6
4
1
1
Buy
11
9
6
8
6
Hold
0
0
0
0
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
17
15
10
9
14
In the current month, BLFS has received 7 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. BLFS average Analyst price target in the past 3 months is 31.00.
Each month's total comprises the sum of three months' worth of ratings.

BLFS Financial Forecast

BLFS Earnings Forecast

Next quarter’s earnings estimate for BLFS is $0.03 with a range of -$0.01 to $0.04. The previous quarter’s EPS was $0.02. BLFS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 43.75% of the time in the same period. In the last calendar year BLFS has Performed in-line its overall industry.
Next quarter’s earnings estimate for BLFS is $0.03 with a range of -$0.01 to $0.04. The previous quarter’s EPS was $0.02. BLFS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 43.75% of the time in the same period. In the last calendar year BLFS has Performed in-line its overall industry.

BLFS Sales Forecast

Next quarter’s sales forecast for BLFS is $27.80M with a range of $26.80M to $28.50M. The previous quarter’s sales results were $27.50M. BLFS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 55.56% of the time in the same period. In the last calendar year BLFS has Performed in-line its overall industry.
Next quarter’s sales forecast for BLFS is $27.80M with a range of $26.80M to $28.50M. The previous quarter’s sales results were $27.50M. BLFS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 55.56% of the time in the same period. In the last calendar year BLFS has Performed in-line its overall industry.

BLFS Stock Forecast FAQ

What is BLFS’s average 12-month price target, according to analysts?
Based on analyst ratings, BioLife Solutions’s 12-month average price target is 31.00.
    What is BLFS’s upside potential, based on the analysts’ average price target?
    BioLife Solutions has 3.40% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is BLFS a Buy, Sell or Hold?
          BioLife Solutions has a consensus rating of Hold which is based on 0 buy ratings, 7 hold ratings and 0 sell ratings.
            What is BioLife Solutions’s price target?
            The average price target for BioLife Solutions is 31.00. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $31.00 ,the lowest forecast is $31.00. The average price target represents 3.40% Increase from the current price of $29.98.
              What do analysts say about BioLife Solutions?
              BioLife Solutions’s analyst rating consensus is a Hold. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of BLFS?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.